Stay updated on Pembrolizumab & Lenalidomide in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Lenalidomide in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Lenalidomide in Lymphoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A sitewide NIH notice about using “Super Intelligence” in place of “Artificial Intelligence” was added, and the footer revision changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T14:37:13.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-13T14:54:13.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a minimal header and a Home link, replacing the previous study record content. This indicates the page is currently inaccessible due to access restrictions.
    Difference
    19%
    Check dated 2026-09-22T22:05:31.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page now displays an updated platform revision tag, v3.7.0, replacing the previous v3.6.6.
    Difference
    0.1%
    Check dated 2026-09-15T22:21:08.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.6.6 appears on the page, replacing v3.6.5; this signals a small update to the page's revision history rather than substantive changes to the study information.
    Difference
    0.1%
    Check dated 2026-09-01T19:35:42.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.4 to v3.6.5 on the page, indicating a minor update to the record's metadata. No substantive study details or results are indicated to be changed.
    Difference
    0.1%
    Check dated 2026-08-11T08:26:25.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Lenalidomide in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Lenalidomide in Lymphoma Clinical Trial page.